Apis Flora Industrial e Comercial Ltda

About us

Founded in 1982, in the city of Ribeirão Preto, in the interior of São Paulo, Apis Flora is a national market leader in the propolis segment (IQVIA/26). The company is acknowledged for consistently allocating funds to research to advance the Brazilian sector and, to this end, has partnerships with research institutions, universities, and development agencies - such as USP, UNICAMP, UNESP, FAEPA, CNPq, FAPESP, and FINEP. Due to these partnerships, it adds up to more than 35 years of research, with over 400 researchers involved, more than 300 published studies, and six patents, among them EPP-AF®, a standardized and exclusive propolis extract that makes up several products in the brand’s portfolio, including PROPOMAX®, used in a world-first study demonstrating the benefits of propolis extract for treating COVID-19. Apis Flora, through EPP-AF®, has created another distinctive and innovative solution: iCaps, a microencapsulation technology that encapsulates propolis particles, resulting in the propolis extract EPP-AF® iCaps. Currently, its products are available in more than forty thousand points of sale, and the brand is present throughout Brazil. It has over one hundred products in its catalog and is a supplier of industrial ingredients for the pharmaceutical, food, and cosmetics industries. In recent years, it has gained relevance among other companies in the sector of appetizers and functional foods worldwide. Today, it exports to more than thirty countries, including China, the United States, Japan, and France.

Specs about this supplier

Products featured at Vitafoods Asia 2025